Welcome to our dedicated page for Precision Optics news (Ticker: POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics stock.
Precision Optics Corporation, Inc. (NASDAQ: POCI) is a vertically integrated optics company focused on advanced optical instruments for healthcare and defense/aerospace markets. This news page aggregates company announcements, press releases and other updates related to POCI’s operations, projects and financial performance.
Readers can follow news about Precision Optics’ work in micro-optics, 3D imaging and digital imaging technologies, including developments in minimally invasive surgery imaging, 3D endoscopy and optical systems that support surgical robotic platforms. Updates often highlight new engineering and production programs, such as complex endocouplers, specialized endoscopes and single-use endoscope assemblies for leading medical device companies.
In defense and aerospace, company news covers product development orders and collaborations involving compact, high-performance optical systems. Recent releases describe sub-assemblies for advanced augmented reality systems for fighter pilot training and high-end, small-diameter borescopes for jet engine inspection in extreme environmental conditions. These items illustrate how Precision Optics applies its micro-optics and imaging capabilities to demanding military and aerospace applications.
Investors and analysts can also review announcements of quarterly and annual financial results, including details on engineering versus production revenue, gross margins, net income (loss) and the company’s use of non-GAAP measures such as Adjusted EBITDA. Conference call schedules, investor conference participation and facility expansion plans, including moves to support a growing production backlog and broader engineering talent pool, are also covered.
For anyone tracking POCI stock or the company’s role in medical and defense/aerospace optics, this page provides a centralized view of official news, helping users understand how new contracts, development agreements and operational updates relate to the company’s long-term strategy.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Precision Optics Corporation (NASDAQ: POCI) announced its participation in the Planet MicroCap Showcase: VEGAS 2023, taking place on April 26-27, 2023. Dr. Joe Forkey, the CEO, will present at the event, with a webcast of the presentation available at 7:00 PM ET on April 26. The presentation will also be archived for later viewing. In addition, the management team will hold one-on-one meetings at the conference venue in Las Vegas. For those interested in booking a meeting, they can contact the event organizers or email POCI directly.
Founded in 1982, Precision Optics specializes in advanced optical instruments for medical and defense applications. The company focuses on micro-optics and 3D imaging technologies, supporting minimally invasive surgeries and surgical robotic systems.
Precision Optics Corporation (NASDAQ: POCI), based in Gardner, Massachusetts, has announced a significant development order worth approximately $1.3 million for a next-generation urological endoscopy program. This order comes from a well-known medical device company and represents a strategic shift for Precision Optics, moving from a component supplier to a developer of complete endoscope imaging systems. The product development will be conducted in collaboration with Lighthouse Imaging, showcasing the company’s expertise in micro-optics, medical systems, and digital imaging. The agreement's completion is anticipated within the next 12 months, paving the way for potential future contracts.
CEO Joe Forkey emphasized that this agreement is a significant opportunity to enhance their role in medical imaging, supporting the increasing demand for integrated optics and electronics in next-generation products.